A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Bleomycin sulfate | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standardsbritish pharmacopoeiaeuropean pharmacopoeia (ph. eur.)pharmacopoeial standards. Alternative Names: Bleomycin, sulfate (salt), Bleomycin sulfate, Blenoxane, Blexane. |  |
| Bleomycin Sulfate | 10mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: N/A. CAS No. 9041-93-4. Prepack ID 25097489-10mg. See USA prepack pricing. |  |
| Bleomycin Sulfate (A2, B2) | A group of related glycopeptide antibiotics. Bleomycin A2 is the main component of the bleomycin employed clinically. Antineoplastic. Mixture of Bleomycin A2, B2 isolated from Streptomyces verticillus. Group: Biochemicals. Alternative Names: Blenoxane; Blexane; Bleo. Grades: Purified. CAS No. 9041-93-4. Pack Sizes: 10mg, 50mg. Molecular Formula: C55H84N17O21S3·xH2SO4, Molecular Weight: 1415.56 (free acid basis). US Biological Life Sciences. |  Worldwide |
| Bleselumab | Bleselumab (ASKP 1240) is a human anti- CD40 monoclonal antibody (mAb). Bleselumab binds to human CD40 with high affinity ( K d : 0.24 nM). Bleselumab inhibits immune responses by blocking the interaction of CD40 with its ligand CD40L. Bleselumab prevents organ transplant rejection [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: ASKP 1240; Anti-Human CD40 Recombinant Antibody. CAS No. 1453067-91-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99257. |  |
| Bletilla Extract | Bletilla Extract. Applications: Use for stop bleeding by astringency, relieving swelling and promoting tissue regeneration. treat haematenesis and tomachache; and with dondey-hide gelatin, dried rehmannia root, biota tops.treat diabrotic skin sorebe. Group: Others. Synonyms: Bletilla Extract; Bletilla striata (Thunb.ex A.Murray)Rchb.f. Purity: 10:1 by TLC. Appearance: Brown yellow fine powder. Storage: 2 years under well storage situation and stored away from direct sun light. Source: Root. Species: Bletilla striata (Thunb.ex A.Murray)Rchb.f. Bletilla Extract; Bletilla striata (Thunb.ex A.Murray)Rchb.f.; plant extract. Pack: 25KG/Drum with double plastic bag of foodstuff inside. Cat No: EXTW-196. |  |
| Bleximenib | Bleximenib (JNJ-75276617; Menin-MLL inhibitor 24) is a potent, selective and orally active menin-KMT2A protein-protein interaction inhibitor with IC 50 values of 0.1, 0.045, ≤0.066 nM for human, mouse, dog, respectively. Bleximenib shows antiproliferative activity and induces apoptosis. Bleximenib has the potential for the research of Acute myeloid leukemia (AML) [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: JNJ-75276617; Menin-MLL inhibitor 24. CAS No. 2654081-35-1. Pack Sizes: 5 mg; 10 mg. Product ID: HY-148669. | |
| Bleximenib oxalate | Bleximenib (JNJ-75276617; Menin-MLL inhibitor 24) oxalate is a potent, selective and orally active menin-KMT2A protein-protein interaction inhibitor with IC 50 values of 0.1, 0.045, ≤0.066 nM for human, mouse, dog, respectively. Bleximenib oxalate shows antiproliferative activity and induces apoptosis. Bleximenib oxalate has the potential for the research of Acute myeloid leukemia (AML) [1] [2]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: JNJ-75276617 oxalate; Menin-MLL inhibitor 24 oxalate. CAS No. 2866179-95-3. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-148669A. | |
| b-L-Fucopyranosylamine | b-L-Fucopyranosylamine is an indispensable compound, used for studying a myriad of ailments, encompassing cancer and autoimmune disorders. Deemed exceptional due to its distinctive attributes, this compound showcases immense efficacy in selectively studying aberrant cell proliferation, while concurrently modulating the intricate immune response. Synonyms: 2-amino-6-methyloxane-3,4,5-triol; B-l-fucopyranosylamine; 103419-79-0; SCHEMBL22779020; AKOS030241001; FT-0668893. CAS No. 103419-79-0. Molecular formula: C6H13NO4. Mole weight: 163.17. |  |
| b-L-Fucopyranosyl nitromethane | b-L-Fucopyranosyl nitromethane is a paramount biomedical compound, standing as a resolute weapon to study a diverse spectrum of afflictions encompassing malignancy and inflammatory disorders. Synonyms: 2,6-Anhydro-1,7-dideoxy-7-nitro-D-glycero-D-galacto-heptitol. Molecular formula: C7H13NO6. Mole weight: 207.2. | |
| b-L-Glucose-1-phosphate ammonium salt | b-L-Glucose-1-phosphate ammonium salt is an indispensable compound fundamental to the research of diverse disorders pertaining to glucose metabolism, encompassing glycogen storage diseases and diabetes. By serving as a synthetic predecessor, it facilitates the compoundion of glucose-1-phosphate is an imperatively significant molecule intricately entwined with glycogen research and development and subsequent energy storage. Molecular formula: C6H19N2O9P. Mole weight: 294.20. | |
| BLI-489 hydrate | BLI-489 hydrate. Uses: Designed for use in research and industrial production. Additional or Alternative Names: 6-[(5,6-Dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid sodium salt hydrate, WA. Product Category: Heterocyclic Organic Compound. CAS No. 623564-40-9. Molecular formula: C13H12N3NaO5S. Mole weight: 327.29 (anhydrous basis). Purity: 0.96. IUPACName: sodium;(5R,6Z)-6-(6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-2-ylmethylidene)-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate;hydrate. Canonical SMILES: C1COCC2=NC(=CN21)C=C3C4N(C3=O)C(=CS4)C(=O)[O-].O.[Na+]. Product ID: ACM623564409. Alfa Chemistry ISO 9001:2015 Certified. |  |
| BLI-489 hydrate | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| BLI 489 Hydrate | BLI-489 is a penem β-lactamase inhibitor, which has shown activity against class A, C, and D β-lactamases. BLI-489 is being tested in combination therapy for drug-resistant bacteria. Group: Biochemicals. Alternative Names: (5R,6Z)-6-[(5,6-Dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)methylene]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic Acid Sodium Salt Hydrate; WAY-185489. Grades: Purified. CAS No. 623564-40-9. Pack Sizes: 5mg, 10mg. Molecular Formula: C??H??N?NaO?S; xH?O, Molecular Weight: 327.29. US Biological Life Sciences. | Worldwide |
| blinatumomab | Blinatumomab is a monoclonal antibody used for the treatment of Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. It effects against tumor cells via binding to a CD3 site for T cells and a CD19 site for the target B cells, which express both in pediatric and adult populations. Uses: The treatment of philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. Synonyms: Blincyto. CAS No. 853426-35-4. Molecular formula: C2367H3577N649O772S19. Mole weight: 54100. | |
| Blinatumomab | Blinatumomab (Anatumomab) is a bispecific monoclonal antibody with two binding sites, one for CD3E on T cells and one for CD19 on B cells. Blinatumomab can be used in research for acute lymphoblastic leukemia [1] [2] [3] [4]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Anatumomab. CAS No. 853426-35-4. Pack Sizes: 100 μg; 500 μg; 1 mg; 5 mg. Product ID: HY-P9963. | |
| Blinin | Blinin is a diterpene originally isolated from C. blini. Uses: Antimalarial. Synonyms: 4-[2-[(1S,2R,4aS,7S,8aR)-4a-[(Acetyloxy)methyl]-1,2,3,4,4a,7,8,8a-octahydro-7-hydroxy-5-(hydroxymethyl)-1,2-dimethyl-1-naphthalenyl]ethyl]-2(5H)-furanone; 2(5H)-Furanone, 4-[2-[(1S,2R,4aS,7S,8aR)-4a-[(acetyloxy)methyl]-1,2,3,4,4a,7,8,8a-octahydro-7-hydroxy-5-(hydroxymethyl)-1,2-dimethyl-1-naphthalenyl]ethyl]-; 4-[2-[(1S,2R,4aS,7S,8aR)-4a-[(Acetyloxy)methyl]-1,2,3,4,4a,7,8,8a-octahydro-7-hydroxy-5-(hydroxymethyl)-1,2-dimethyl-1-naphthalenyl]ethyl]-2(5H)-furanone. Grades: >98%. CAS No. 125675-09-4. Molecular formula: C22H32O6. Mole weight: 392.49. | |
| B-LIPOTROPIN FRAGMENT 14-17 HUMAN | B-LIPOTROPIN FRAGMENT 14-17 HUMAN. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Asn-ala-gly-ala, Asparaginyl-alanyl-glycyl-alanine, CID5487694, L-Alanine, N-(N-(N-L-asparaginyl-L-alanyl)glycyl)-, 84268-42-8. Product Category: Heterocyclic Organic Compound. CAS No. 84268-42-8. Molecular formula: C12H21N5O6. Mole weight: 331.325040 [g/mol]. Purity: 0.96. IUPACName: (2S)-2-[[2-[[(2S)-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]propanoyl]amino]acetyl]amino]propanoic acid. Canonical SMILES: CC(C(=O)NCC(=O)NC(C)C(=O)O)NC(=O)C(CC(=O)N)N. Product ID: ACM84268428. Alfa Chemistry ISO 9001:2015 Certified. | |
| Bliretrigine | Bliretrigine is a sodium channel blocker. Bliretrigine has the effect of relieving pain [1] [2] [3]. Uses: Scientific research. Group: Signaling pathways. CAS No. 1233229-75-8. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-145558. | |
| BLM Helicase Inhibitor, ML216 (ML-216, 1- (4-Fluoro-3- (trifluoromethyl) phenyl) -3- (5- (pyridin-4-yl) -1, 3, 4-thiadiazol-2-yl) urea) | A cell-permeable pyridinyl-thiadiazolylurea compound that selectively blocks Bloom's syndrome protein (BLM) helicase activity of both full-length as well as truncated BLM636-1298 forms (IC50 = 2.98 and 0.97uM, respectively). Competes with and reversibly blocks DNA binding to BLM. However, the inhibition appears to be non-competitive with respect to ATP. Exhibits anti-proliferative activity in cells expressing BLM, but not in those lacking BLM. Induces sister chromatid exchanges (SCEs) and enhances the sensitivity of BLM containing PSNF5 cells to aphidicolin without affecting PSNG13 cells that are devoid of BLM. Displays favorable microsomal (T1/2 > 1.2h) and plasma stability (~100% at 5h). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 10mg. Molecular Formula: C??H?F?N?OS. US Biological Life Sciences. | Worldwide |
| Block polymers | Our wide distribution network, with locations coast-to-coast, helps guarantee fast, reliable service to Univar's customers. |  |
| Blonanserin | A 5-HT2 serotonin receptor and D2 dopamine receptor antagonist, used as an antipsychotic. Group: Biochemicals. Alternative Names: 2-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-cycloocta[b]pyridine; Lonasen; AD 5423. Grades: Highly Purified. CAS No. 132810-10-7. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Blonanserin | Blonanserin (AD-5423) is a potent and orally active 5-HT 2A ( K i =0.812 nM) and dopamine D2 receptor ( K i =0.142 nM) antagonist. Blonanserin is usually acts as an atypical antipsychotic agent and can be used for the research of extrapyramidal symptoms, excessive sedation, or hypotension [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: AD-5423. CAS No. 132810-10-7. Pack Sizes: 10 mM * 1 mL; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-13575. | |
| Blonanserin | A 5-HT2 serotonin receptor and D2 dopamine receptor antagonist, used as an antipsychotic. Synonyms: 2-(4-ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine. Grades: 0.99. CAS No. 132810-10-7. Molecular formula: C23H30FN3. Mole weight: 367.512. | |
| Blonanserin | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Blonanserin Impurity 1 | Blonanserin Impurity 1 is an impurity of blonanserin pharmaceutical formulations. Blonanserin is an atypical antipsychotic medication used in the therapy of schizophrenia and other related mental disorders. Synonyms: Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro-. Grades: > 95%. CAS No. 1648791-23-4. Molecular formula: C29H43N5. Mole weight: 461.70. | |
| Blonanserin Impurity 14 | Blonanserin Impurity 14. Uses: For analytical and research use. Group: Impurity standards. CAS No. 132813-14-0. Molecular formula: C17H17ClFN. Mole weight: 289.78. Catalog: APB132813140. | |
| Blonanserin Impurity 2 | Blonanserin Impurity 2 is an impurity of blonanserin used in the therapy of various mental disorders, including schizophrenia and bipolar disorder. Blonanserin acts as a potent antagonist at dopamine D2 and serotonin 5-HT2 receptors, effectively treating symptoms associated with these conditions. Synonyms: Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-5,6,7,8,9,10-hexahydro-4-phenyl-. Grades: > 95%. CAS No. 132810-75-4. Molecular formula: C23H31N3. Mole weight: 349.52. | |
| Blonanserin Impurity 21 | Blonanserin Impurity 21. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(4-ethylpiperazin-1-yl)-4-(4-methoxyphenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine. CAS No. 132810-93-6. Molecular formula: C24H33N3O. Mole weight: 379.54. Catalog: APB132810936. | |
| Blonanserin Impurity 26 | Blonanserin Impurity 26. Uses: For analytical and research use. Group: Impurity standards. CAS No. 132813-22-0. Molecular formula: C17H17Cl2N. Mole weight: 306.23. Catalog: APB132813220. | |
| Blonanserin Impurity 27 | Blonanserin Impurity 27. Uses: For analytical and research use. Group: Impurity standards. CAS No. 132813-16-2. Molecular formula: C17H17ClFN. Mole weight: 289.78. Catalog: APB132813162. | |
| Blonanserin Impurity 28 | Blonanserin Impurity 28. Uses: For analytical and research use. Group: Impurity standards. CAS No. 132813-15-1. Molecular formula: C17H17ClFN. Mole weight: 289.78. Catalog: APB132813151. | |
| Blonanserin Impurity 29 | Blonanserin Impurity 29. Uses: For analytical and research use. Group: Impurity standards. CAS No. 132813-13-9. Molecular formula: C17H18ClN. Mole weight: 271.79. Catalog: APB132813139. | |
| Blonanserin Impurity 30 | Blonanserin Impurity 30. Uses: For analytical and research use. Group: Impurity standards. CAS No. 132813-20-8. Molecular formula: C18H20ClNO. Mole weight: 301.81. Catalog: APB132813208. | |
| Blonanserin Impurity 4 | Blonanserin Impurity 4 is an intermediate in the synthesis of Blonanserin. Synonyms: Blonanserin C; 4-(4-Fluorophenyl)-5,6,7,8,9,10-hexahydro-2-(1-piperazinyl)cycloocta[b]pyridine. Grades: > 95%. CAS No. 132811-84-8. Molecular formula: C21H26FN3. Mole weight: 339.46. | |
| Blonanserin Impurity 6 | Blonanserin Impurity 6. Uses: For analytical and research use. Group: Impurity standards. CAS No. 132810-83-4. Molecular formula: C23H30FN3. Mole weight: 367.51. Catalog: APB132810834. | |
| Blonanserin Impurity 6 | Blonanserin Impurity 6 is an impurity of blonanserin, aiding in the therapy of a myriad of intricate mental disorders, encompassing schizophrenia and bipolar disorder. Grades: > 95%. CAS No. 132810-83-4. Molecular formula: C23H30FN3. Mole weight: 367.51. | |
| Blonanserin Impurity 9 | Blonanserin Impurity 9. Uses: For analytical and research use. Group: Impurity standards. CAS No. 132810-87-8. Molecular formula: C23H30ClN3. Mole weight: 383.96. Catalog: APB132810878. | |
| blonanserin impurity A | blonanserin impurity A. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-(4-ethylpiperazin-1-yl)-4-phenyl-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine. CAS No. 132810-75-4. Molecular formula: C23H31N3. Mole weight: 349.51. Catalog: APB132810754. | |
| blonanserin impurity C | blonanserin impurity C. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 4-(4-fluorophenyl)-2-(piperazin-1-yl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine. CAS No. 132811-84-8. Molecular formula: C21H26FN3. Mole weight: 339.45. Catalog: APB132811848. | |
| Blonanserin N-Oxide | Blonanserin N-Oxide. Uses: For analytical and research use. Group: Impurity standards. Pack Sizes: 10MG. Catalog: APS006171. Format: Neat. Shipping: Room Temperature. | |
| Blood-coagulation factor VIII | Blood-coagulation factor VIII. Uses: Designed for use in research and industrial production. Additional or Alternative Names: Blood-coagulation factor VIII;Thromboplastinogen;Beroctocog alfa. Product Category: Heterocyclic Organic Compound. CAS No. 9001-27-8. Purity: 0.96. Product ID: ACM9001278. Alfa Chemistry ISO 9001:2015 Certified. Categories: Blood-coagulation factor VIIa. | |
| Blood group A-BSA (6 atom spacer) | Blood group A-BSA (6 atom spacer), a biomedical diagnostic and therapeutic product, finds application in certain specific blood disorders. Widely used to differentiate and identify A and B blood types, it provides superior accuracy and sensitivity thanks to the 6 atom spacer, which amplifies its clinical value. | |
| Blood Group A disaccharide | 2-O-(a-L-Fucopyranosyl)-D-galactose Fuca1®2Gal. Product ID: 3-00408. Molecular formula: C12H22O10. Mole weight: 326.3. Properties: GalNAca1-3(Fuca1-2)Gal. |  |
| Blood Group A-HAS | | |
| Blood group A-HSA | | |
| Blood group A-HSA (6 atom spacer) | Blood group A-HSA (6 atom spacer), a purpose-built protein at the forefront of biomedical discovery and innovation, serves as a fundamental tool in the analysis of ABO(H) blood types. Used extensively in the study of blood transfusion, hematology, and immunology, this product represents a powerful weapon against disease. Its vital role in identifying appropriate blood groups for safe transfusions and treatment of related illnesses cannot be overstated. | |
| Blood Group A-HSA (Globulin Free 6-Atom Spacer) | Blood Group A-HSA (Globulin Free 6-Atom Spacer) is a highly specialized reagent widely employed in the field of blood transfusion medicine. Its primary function is to identify the A antigen in blood samples with remarkable precision, thanks to its 6-atom spacer molecule that enhances both sensitivity and specificity. In a clinical context where just a minor oversight can cause grave harm to the patient, this reagent plays a pivotal role in ensuring that only safe and compatible blood transfusions are performed on individuals with the A blood type. | |
| Blood Group A pentasaccharide | Blood Group A pentasaccharide is a specific carbohydrate molecule commonly used in the biomedical industry for blood typing and transfusion purposes. It is utilized to determine an individual's blood type, specifically Blood Group A. This information is crucial in blood transfusions to ensure compatibility and prevent adverse reactions. Synonyms: GalNAca1-3(Fuca1-2)Galb1-4(Fuca1-3)Glc; blood group A antigen pentaose type 1; D-Glucose, O-2-(acetylamino)-2-deoxy-α-D-galactopyranosyl-(1?3)-O-[6-deoxy-α-L-galactopyranosyl-(1?2)]-O-β-D-galactopyranosyl-(1?4)-O-[6-deoxy-α-L-galactopyranosyl-(1?3)]-; α-D-GalNAc-(1-3)-[α-L-Fuc-(1-2)]-β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-D-Glc; 2-Acetamido-2-deoxy-α-D-galactopyranosyl-(1->3)-[(5S)-5-ethyl-β-D-arabinopyranosyl-(1->2)]-β-D-galactopyranosyl-(1->4)-[(5S)-5-ethyl-β-D-arabinopyranosyl-(1->3)]-D-glucopyranose. Grades: ≥90%. CAS No. 50624-46-9. Molecular formula: C32H55NO24. Mole weight: 837.77. | |
| Blood Group A tetrasaccharide type 5 | Blood Group A tetrasaccharide type 5 is a crucial component specifically targeting and interacting with blood group antigens present on red blood cells with Blood Group A. This tetrasaccharide type 5 is utilized to study and understand the immunogenicity and variation of Blood Group A antigens. Synonyms: GalNAca1-3(Fuca1-2)Galb1-4Glc; Blood Group A tetrasaccharide type V; Blood group A type 5 tetrasaccharide; Alpha-Tetrasaccharide; a-D-GalNAc-(1->3)[a-L-Fuc-(1->2)]-b-D-Gal-(1->4)-D-Glc; O-2-(acetylamino)-2-deoxy-a-D-galactopyranosyl-(1->3)-O-[6-deoxy-a-L-galactopyranosyl-(1->2)]-O-b-D-galactopyranosyl-(1->4)-D-Glucose. Grades: ≥90%. CAS No. 59957-92-5. Molecular formula: C26H45NO20. Mole weight: 691.63. | |
| Blood Group A trisaccharide | Blood Group A trisaccharide. CAS No. 49777-13-1. Product ID: 3-00409. Molecular formula: C20H35O15. Mole weight: 529.5. Properties: Gala1-3(Fuca1-2)Gal. | |
| Blood Group A trisaccharide | Blood Group A Trisaccharide is a trisaccharide compound used in the biomedical industry for blood typing and transfusion medicine. It is specifically designed for treating individuals with blood group A, where it helps determine compatibility for blood transfusions and identify potential antibody reactions. Synonyms: GalNAc-a-1,3-(Fuc-a-1,2)Gal; Trisaccharide A; A-trisaccharide hapten; α-D-GalNAc-(1?3)-(α-L-Fuc-[1?2])-D-Gal; 2-Acetamido-2-deoxy-α-D-galactopyranosyl-(1->3)-[6-deoxy-α-L-galactopyranosyl-(1->2)]-D-galactopyranose. Grades: ≥95%. CAS No. 49777-13-1. Molecular formula: C20H35NO15. Mole weight: 529.49. | |
| Blood Group A trisaccharide-APE,Biotin-BSA | Blood Group A trisaccharide-APE is an essential compound used in compound for the detection and identification of blood group A antigens. It acting as a specific probe for identifying individuals with blood type A and plays a crucial role in blood transfusion compatibility testing and forensic investigations. while Biotin-BSA is a valuable compound extensively utilized in the biomedical industry. It serving as an important tool for numerous applications including immunohistochemistry, ELISA assays is and protein labeling. Biotin-BSA conjugates enable the specific detection and visualization of different biomolecules, proteins, or antibodies in various diagnostic and research settings. Synonyms: GalNAc-a-1,3-(Fuc-a-1,2)Gal-APE-[Biotin]-BSA. | |
| Blood Group A trisaccharide-biotin | Blood Group A trisaccharide-biotin, a biomolecule featuring prominently in carbohydrate-protein interaction research, offers a valuable tool for detecting and isolating carbohydrate-binding proteins like blood group antigens. Its practical functions are particularly significant within the clinical field, like studies involving blood transfusions and blood group polymorphisms. Molecular formula: C39H67N5O18S. Mole weight: 925.42. | |
| Blood Group A trisaccharide-BSA | Blood Group A trisaccharide-BSA is an Invaluable biomedical research tool unraveling the intricate complexities surrounding blood group antigens and their enigmatic interactions. Adopted prevalently within the biomedical research domain, it is used for the research of A antigen in both blood transfusion reactions and the enigma-laden realm of autoimmune diseases. Synonyms: GalNAc-a-1,3-(Fuc-a-1,2)Gal-BSA. | |
| Blood Group A trisaccharide-(CH2)8COOMe derivative | Blood Group A trisaccharide-(CH2)8COOMe derivative is a synthetic derivative designed to mimic the structure of the Blood Group A trisaccharide antigen. This compound has potential applications in biomedicine, particularly in diagnostic tests and vaccine development for detecting and studying diseases related to Blood Group A antigens. CAS No. 68733-37-9. Molecular formula: C30H53NO17. Mole weight: 699.74. | |
| Blood group A trisaccharide ester derivative | Blood group A trisaccharide ester derivative is a paramount compound employed in biomedical research assuming a pivotal stance in the exploration and comprehension of distinct interactions pertaining to the A antigen prevailing on erythrocytes. Molecular formula: C30H53NO17. Mole weight: 699.74. | |
| Blood Group A trisaccharide, N-aminoethyl nonanamide | Blood Group A trisaccharide, N-aminoethyl nonanamide is an indispensable compound specifically tailored for studying the distinctive requirements of Blood Group A individuals. This compound unfolds a pivotal role in the expedition of blood transfusion drugs. Synonyms: GalNAc-a-1,3-(Fuc-a-1,2)Gal-b1-O-(CH2)8CONH(CH2)2NH2; Blood group A trisaccharide amine derivative; 9-[[O-2-(Acetylamino)-2-deoxy-alpha-D-galactopyranosyl-(1-3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1-2)]-alpha-D-galactopyranosyl]oxy]-N-(2-aminoethyl)nonanamide. Grades: ≥90%. CAS No. 170298-33-6. Molecular formula: C31H57N3O16. Mole weight: 727.79. | |
| Blood group A trisaccharide Sepharose 4B | AFFINIDEXTM-A conjugated to Sepharose 4B via a 10 atom spacer. | |
| Blood Group A Trisaccharide Sepharose FF | AFFINIDEXTM-A conjugated to Sepharose FF via a 10 atom spacer. | |
| Blood Group A trisaccharide, spacer-biotin conjugate | Blood Group A trisaccharide, spacer-biotin conjugate is an indispensable and pivotal instrument in the realm of biomedical research. Its astute design empowers researchers to delve deeper into the intricacies of blood group-related afflictions, granting the ability to discern and apprehend the elusive Blood Group A antigen with utmost precision. Synonyms: Fuc-(a1,2)-[GalNAc-(a1,3)]-b-Gal-O(CH2)3NHCO(CH2)5NH-biotin. CAS No. 870891-83-1. Molecular formula: C39H67N5O18S. Mole weight: 926.04. | |
| Blood group A type 1 linear trisaccharide-NGL | Blood group A type 1 linear trisaccharide-NGL, a carbohydrate of utmost importance, has been considered a potential vaccine candidate for bacterial infections owing to its peculiar interaction mechanism with proteins. Additionally, it tremendously aids the production of glycan microarrays for the screening of carbohydrate-binding proteins, but that's not all. Extensive research and numerous studies have revealed its crucial role in the cancer development and progression. Overall, this trisaccharide definitely deserves to be studied and explored further. | |
| Blood group A type 1 tetrasaccharide-NGL | Blood group A type 1 tetrasaccharide-NGL, a synthetic carbohydrate antigen, boasts of its potential as an effective cancer treatment strategy by selectively targeting and modulating the host immune system. This intriguing tetrasaccharide is capable of thwarting cancer cell metastasis, including in breast and colon cancers. Furthermore, it serves as a principal target agent for engineering glycoconjugate vaccines against bacterial infections caused by certain strains harbouring the infamous ABO blood group antigen. | |
| Blood group A type 2 linear trisaccharide-NGL | Blood group A type 2 linear trisaccharide-NGL is a biomolecule used in the development of blood transfusion protocols and in studying blood group antigen-antibody interactions. It is also an important component for understanding the pathogenesis of infectious diseases like Helicobacter pylori and Campylobacter jejuni that use blood group antigens as receptors. | |
| Blood group A type 2 tetrasaccharide | Blood group A type 2 tetrasaccharide - a complex carbohydrate that adorns the surface of red blood cells of those with blood type A - has been known to interfere with certain human diseases, such as cancer and autoimmune disorders, while simultaneously serving as a mediator for testing and typing blood. Scholars are expeditiously exploring its promising role in targeting disease-related inflammation as a future therapeutic. Synonyms: GalNAca-3(fuca-2)Galb-4GlcNAc; A type 2; blood group A antigen type 2; alpha-D-GalNAc-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-beta-D-GlcNAc; 2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)-[6-deoxy-alpha-L-galactopyranosyl-(1->2)]-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose; Blood Group A tetrasaccharide type II. Grades: ≥95%. CAS No. 73361-87-2. Molecular formula: C28H48N2O20. Mole weight: 732.68. | |
| Blood group A type 2 tetrasaccharide-NGL | Blood group A type 2 tetrasaccharide-NGL, a carbohydrate antigen indispensable for identifying diversified blood groups, boasts significant potential for cancer research. This tetrasaccharide serves as a robust tool for studying glycosylation changes within cancer cells and diagnosing specific types of tumors. Its therapeutic potential, namely for creating vaccines to fight cancer, has also been explored, rendering it an area of active investigation. | |
| Blood group A type 3/4 linear trisaccharide | Blood group A type 3/4 linear trisaccharide is a biomolecule used in the biomedical industry playing a crucial role in identifying and studying blood group antigens, specifically those associated with blood type A. This trisaccharide is used in the development of drugs and therapies aimed at studying diseases related to blood group phenotypes. Molecular formula: C22H38N2O16. Mole weight: 586.54. | |
| Blood group A type 3/4 tetrasaccharide | Blood group A type 3/4 tetrasaccharide is a synthetic saccharide used in the compound industry for the study and identification of blood group A. It is also utilized in the development of diagnostic tools and assays for detecting ABO antigens in blood typing and transfusion compatibility testing. Molecular formula: C28H48N2O20. Mole weight: 732.68. | |
| Blood group A type 3 linear trisaccharide-NGL | Blood group A type 3 linear trisaccharide-NGL plays an important role in the biomedical industry as it is a potential diagnostic and therapeutic target for cancers, particularly ovarian cancer. It can serve as a biomarker to assess the progression and prognosis of the disease, allowing for earlier detection and more personalized treatment options. Additionally, research has shown that targeting this trisaccharide can lead to improved response to chemotherapy and increased overall survival in ovarian cancer patients. | |
| Blood group A type 3 tetrasaccharide-NGL | Blood group A type 3 tetrasaccharide-NGL is a distinctive glycan molecule that is deployed as a diagnostic tool for deciphering blood group A epitopes on human erythrocytes, as well as a crucial molecule in certain malignant neoplasms and autoimmune maladies in which abnormal blood group antigen expression ensues. Through the analysis of Blood group A type 3 tetrasaccharide-NGL, new insights on glycans' implications in disease and wellbeing have emerged, leading to a more comprehensive understanding of these complex biological macromolecules. | |
| Blood group A type 4 linear trisaccharide-NGL | |
Our database is helping our users find suppliers everyday.
